Menu

News & Insights

  • Clear

AGs Inject Accountability into Pharma Practices via $202M Gilead Settlement

New York AG Letitia James, along with a bipartisan coalition of 48 other AGs and in coordination with the U.S. DOJ, announced a $202 million settlement in principle with Gilead Sciences, Inc. (“Gilead”), to resolve allegations that the company ran an illegal kickback scheme to promote medications. According to the AG’s press release, Gilead violated…

Read More

Democratic AGs Sue HHS, DHS Over Alleged Health Data Sharing

20 Democratic AGs sued HHS and DHS for allegedly sharing personal health data with ICE. The complaint alleges that the Centers for Medicare & Medicaid Services—a division of HHS—transferred millions of individuals’ Medicaid records (which include sensitive personal and health information) to DHS without notice or consent, in violation of the Administrative Procedures Act and…

Read More

Connecticut Loses It with Companies Selling “Research Grade” GLP-1 Drugs

Connecticut AG William Tong announced enforcement actions against companies that allegedly advertised, distributed, or sold so-called “research grade” versions of GLP-1 weight loss drugs in violation of state consumer protection laws. The AG sued Triggered Brand for allegedly marketing and selling “research grade” versions of GLP-1 drugs that do not have FDA approval for human…

Read More

Democratic AGs Mount Fevered Challenge to Proposed Rule Impacting Affordable Care Act

A group of 22 Democratic AGs submitted comments opposing the Centers for Medicare and Medicaid Services’s (CMS) Proposed Rule, which would change enrollment, eligibility, and coverage under the Patient Protection and Affordable Care Act (ACA). In their comments, the AGs urge CMS to withdraw the Proposed Rule, contending that the contemplated changes—which include forcing state ACA…

Read More